HealO Medical - Healing Faster For Less™
HealO Medical, LLC™, is a US-headquartered medical device company with transformational technology in wound therapeutics.
Our mission is to provide the most advanced wound therapies for hyper-accelerated healing without painful dressing changes.
Founded by Dr. Edward Lin, a physician, scientist and inventor, HealO’s advanced wound care system, O-ACE-Sys™ has won two national awards, the support of preeminent wound care experts at renowned US medical centers, as well as a 5 million RMB Leading Pioneer Award from China.
In the US, HealO’s O-ACE-Sys™ technology will impact and shape the way $35 billion is spent annually to treat 6 million chronic wounds. By the year 2020, the cost of treating diabetic foot ulcers alone is projected to attain $200 billion.
See sample chronic wound photos (Warning: graphic images)
The wound care market is undergoing double digit growth due to the convergence of 5 aggravating major epidemiologic factors:- Number of diabetics has more than doubled: Worldwide incidence of diabetes increased from 171 million in 2000 to 366 million today (International Diabetes Federation, 9/14/11).
- Aging population compounds wound care burden with more peripheral vascular diseases.
- 78 million aging baby boomers in the US
- 300 million over age 65 in China
- A “supersize” obesity epidemic will result in even more diabetes and vascular diseases.
Based on current trends, 50% of adults in US will be obese by 2030 (Lancet, August 23, 2011);
In 2008, 205 million men and 297 million women globally were obese. An additional 1.5 billion adults were overweight. - Rising incidence of drug-resistant microbes = persistent infections that will be harder than ever to treat.
- A virtually dry antibiotic pipeline = bleak outlook for infected wounds and continued slow-healing.
HealO plans to introduce innovative and cost effective wound healing solutions for the benefit of patients, healthcare professionals and our investors.